Paradigms of public-private partnerships in end-stage renal disease care: The National Kidney Foundation Singapore

Kidney International, Supplement

Volumn 63, Issue 83, 2003, Pages

  Ramirez, Sylvia Paz B ^a   Durai, T T ^b   Hsu, Stephen I Hong ^b  

^a National Kidney Foundation   (Singapore)

^b NONE

Author keywords

ESRD; Funding; Prevention of renal disease; Public private partnership; Social entrepreneurship

Indexed keywords

AZITHROMYCIN;

CHRONIC KIDNEY DISEASE; CONFERENCE PAPER; COST OF ILLNESS; DIALYSIS; DRUG INDUSTRY; HEALTH CARE COST; HEALTH CARE FACILITY; HEALTH CARE MANAGEMENT; HEALTH PROGRAM; HEMODIALYSIS; HUMAN; INFECTION CONTROL; KIDNEY TRANSPLANTATION; NON PROFIT ORGANIZATION; ORGANIZATION; PREVENTIVE HEALTH SERVICE; PRIORITY JOURNAL; PUBLIC HEALTH; PUBLIC HEALTH SERVICE; SCREENING; SINGAPORE; SOCIAL ASPECT; TRACHOMA; TREATMENT OUTCOME; CHRONIC KIDNEY FAILURE; NEPHROLOGY; ORGANIZATION AND MANAGEMENT; RENAL REPLACEMENT THERAPY; REVIEW;

FOUNDATIONS; HUMANS; KIDNEY FAILURE, CHRONIC; NEPHROLOGY; PRIVATE SECTOR; PUBLIC SECTOR; RENAL DIALYSIS; SINGAPORE;

EID: 0037246023     PISSN: 00986577     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1523-1755.63.s83.21.x     Document Type: Conference Paper

References (30)

1. XUE JL, MA JZ, LOUIS TA, COLLINS AJ: Forecast of the number of patients with end-stage renal disease in the United States to the year 2010. J Am Soc Nephrol 12:2753-2758, 2001
2. LYSAGHT MJ: Maintenance dialysis population dynamics: Current trends and long-term implications. J Am Soc Nephrol 13(Suppl 1):S37-S40, 2002
3. CHUGH KS, JHA V: Differences in the care of ESRD patients worldwide: Required resources and future outlook. Kidney Int 48 (Suppl 50):S7-S13, 1995
4. IKELS C: Kidney failure and transplantation in China. Soc Sci Med 44:1271-1283, 1997
5. GARG PP, DIENER-WEST M, POWE NR: Income-based disparities in outcomes for patients with chronic kidney disease. Semin Nephrol 21:377-385, 2001
6. ALTER DA, NAYLOR CD, AUSTIN P, TU JV: Effects of socioeconomic status on access to invasive cardiac procedures and on mortality after acute myocardial infarction. N Engl J Med 341:1359-1367, 1999
7. LANTZ PM, HOUSE JS, LEPKOWSKI JM, et al: Socioeconomic factors, health behaviors and mortality: Results from a nationally representative prospective study of US adults. JAMA 279:1703-1708, 1998
8. RAMIREZ SPB, HSU SIH, NANDAKUMAR M, et al: Funding ESRD care through charity: The paradigm of the National Kidney Foundation of Singapore. Semin Nephrol 21:411-418, 2001
9. BUSE K, WALT G: Global public-private partnerships: part I- A new development in health? Bull World Health Organ 78:549-561, 2000
10. REICH MR: Public-private partnerships for public health. Nat Med 6:617-620, 2000
11. WIDDUS R: Public-private partnerships for health: Their main targets, their diversity, and their future directions. Bull World Health Organ 79:713-720, 2001
12. FROST L, REICH MR, FUJISAKI T: A partnership for ivermectin: Social worlds and boundary objects, in Public-Private Partnerships for Public Health, edited by REICH MR, Cambridge, Harvard Center for Population and Development Studies, 2002, pp 87-114
13. BUSE K, WALT G: Global public-private partnerships: part II- What are the health issues for global governance. Bull World Health Organ 78:699-709, 2000
14. BARRETT D, AUSTIN J, MCCARTHY S: Cross-sector collaboration: Lessons from the International Trachoma Initiative, in Public-Private Partnerships for Public Health, edited by REICH MR, Cambridge, Harvard Center for Population and Development Studies, 2002, pp 41-65
15. AUSTIN JE: The Collaboration Challenge: How Nonprofits and Businesses Succeed Through Strategic Alliances. San Francisco, Jossey-Bass, 2000
16. INITIATIVE ON PUBLIC-PRIVATE PARTNERSHIPS FOR HEALTH. http://www.ipph.org/searc/diseases_list.ctm
17. LUCAS AO: Public-private partnerships: Illustrative examples, in Public-private Partnerships for Public Health, edited by REICH MR, Cambridge, Harvard Center for Population and Development Studies, 2002, pp 19-40
18. KALE OO: Onchocerciasis: The burden of disease. Ann Trop Med Parasitol 92(Suppl 1):S101-115, 1998
19. BOUSSINESQ M, PROD'HON J, CHIPPAUX JP: Onchocerca volvulus: Striking decrease in transmission in the Vina valley (Cameroon) after eight annual large-scale ivermectin treatments. Trans R Soc Trop Med Hygi 91:82-86, 1997
20. WOODS HF, DURAI TT: Funding the bridge to renal transplantation: The National Kidney Foundation of Singapore model. Transplant Proc 24:2070-2072, 1992)
21. WOO KT: GSL: First Report of the Singapore Renal Registry 1997, Singapore, Continental Press Pte Ltd, 1998
22. HOLLEY J, NESPOR S: An analysis of factors affecting employment of chronic dialysis patients. Am J Kidney Dis 23:681-685, 1994
23. KUTNER NG, BROGAN D, FIELDING B: Employment status and ability to work among working-age chronic dialysis patients. Am J Nephrol 11:334-340, 1991
24. MEDICAL DIRECTORATE NATIONAL KIDNEY FOUNDATION OF SINGAPORE: 2001 Annual Report, Singapore, NKF, 2001
25. RAMIREZ SPB, HSU SIH, MCCLELLAN W. Taking a public health approach to the prevention of end-stage renal disease: The NKF Singapore program. Kidney Int 63(Suppl 83):S61-S65, 2003
26. RAMIREZ SPB, MCCLELLAN W, PORT FK, HSU SIH: Risk factors for proteinuria in a large, multiracial, Southeast Asian population. J Am Soc Nephrol 13:1907-1917, 2002
27. RAMIREZ SP, HSU SI, MCCLELLAN W: Low body weight is a risk factor for proteinuria in a multi-racial Southeast Asian pediatric population. Am J Kidney Dis 38:1045-1054, 2001
28. PORTER ME, KRAMER MR: Philanthropy's New Agenda. Harv Bus Rev November-December:121-130, 1999
29. DEES J.G: Social entrepreneurship, in Enterprising Non-profits: A Toolkit for Social Entrepreneurs, edited by DEES J.G, EMERSON J, ECONOMY P, Toronto, John Wiley and Sons, 2001, pp 1-18
30. NATIONAL KIDNEY FOUNDATION (NKF) KIDNEY DISEASE OUTCOME QUALITY INITIATIVE (K/DOQI) ADVISORY BOARD: K/DOQI clinical practice guidelines for chronic kidney disease: Evaluation, classification, and stratification. Kidney Disease Outcome Quality Initiative. Am J Kidney Dis 39(Suppl 2):S246, 2002